Remote Senior Pharmacometric Director: PK Modeling

Allucent; United States; Hybrid; USD 180,000 - 240,000; Full time

Benefits offered by this job

Flexible working hours

Remote/Hybrid depending on location

Leadership and mentoring opportunities

Internal training budget

Career progression

Job summary

Allucent is seeking an Associate Director/Director, Pharmacometrician to lead population PK analyses within CPMS. You will guide teams, mentor pharmacometricians, and provide strategic input to clients at key development milestones, including regulatory interactions.

In this role you will design, analyze, and interpret clinical pharmacology studies, develop innovative approaches to improve efficiency, and contribute to regulatory documents.

Qualifications

• 6–10 years of drug development and pharmacometrics experience.
• Proficiency with NONMEM, Pirana and R.
• Regulatory submissions experience including INDs, CTAs, NDA/BLA/MAA submissions.

Responsibilities

• Lead population PK analyses using advanced modeling tools.
• Develop innovative approaches to enhance PK analysis efficiency and accuracy.
• Design, analyze, and interpret clinical pharmacology studies and provide guidance for sampling and dosing strategies.
• Provide strategic guidance to clients, owning deliverables and developing clinical pharmacology plans.
• Author and review PK reports and regulatory documents sections.
• Represent clients in regulatory interactions and contribute to business development.

Skills

Population PK analyses

Regulatory experience

Client leadership

Strategic thinking

Education

Life science degree

Tools

NONMEM

Pirana

R

Job description

Allucent is seeking an Associate Director/Director, Pharmacometrician to lead population PK analyses within CPMS. You will guide teams, mentor pharmacometricians, and provide strategic input to clients at key development milestones, including regulatory interactions.

In this role you will design, analyze, and interpret clinical pharmacology studies, develop innovative approaches to improve efficiency, and contribute to regulatory documents.